Summary
Updated Aug 30, 2026
Stephen L. Sabba is Director of LIGAND PHARMACEUTICALS INC (LGND). 4 SEC Form 4 filings on record, most recently on 18 June 2026. Most recent open-market trade: sold $545K of LGND on 18 June 2026. Lifetime open-market sales: $1.16M.
Recent Transactions
6Every recent SEC Form 4 transaction Stephen L. Sabba has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen L. Sabba files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Octavio Espinoza - $13.03M of LGND open-market activity in the last 12 months
- Andrew Reardon - $7.34M of LGND open-market activity in the last 12 months
- Jason Haas - $3.74M of LGND open-market activity in the last 12 months
- Jason Aryeh - $2.96M of LGND open-market activity in the last 12 months
- John L. Lamattina - $2.44M of LGND open-market activity in the last 12 months
- Nancy Ryan Gray - $1.35M of LGND open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Stephen L. Sabba?
Stephen L. Sabba is a corporate insider, tracked as Director of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Stephen L. Sabba submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Stephen L. Sabba been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($1.16M) across all tracked filings.
Where can I see all of Stephen L. Sabba's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Stephen L. Sabba and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
